Our data suggest that high insulin requirements observed in patients with severe COVID‐19 are related to the severity of respiratory failure and pre‐existing diabetes mellitus rather than a direct diabetogenic effect of SARS‐CoV‐2. The gene discussed is INS; the disease is respiratory failure.